Episode

Immune Booster 28: Immunometabolism, Inflammation, and Building Biotechs with Luke O'Neill

Podcast
Immune
Published
May 5, 2026
Duration seconds
2696
Processing state
not_requested
Canonical source
https://www.microbe.tv/immune/immune-booster028/
Audio
https://traffic.libsyn.com/secure/immune/Immune_Booster028.mp3?dest-id=595701
JSON
/v1/public/podcasts/immune-453696/episodes/immune-booster-28-immunometabolism-inflammation-and-building-biotechs-with-luke-o-neill
Markdown
/podcast/immune-453696/immune-booster-28-immunometabolism-inflammation-and-building-biotechs-with-luke-o-neill.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/immune-453696/episodes/immune-booster-28-immunometabolism-inflammation-and-building-biotechs-with-luke-o-neill/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/immune-453696/immune-booster-28-immunometabolism-inflammation-and-building-biotechs-with-luke-o-neill.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Luke O'Neill recounts his role in discovering key components of the TLR signaling pathway, explains how pursuing unexpected research questions keeps him motivated, and reflects on his experiences as an entrepreneur founding biotech companies. Host: Cindy Leifer Guest: Luke O'Neill Subscribe (free): Apple Podcasts , RSS , email Become a patron of Immune! Links for this episode MicrobeTV Discord Server O'Neill lab Identification of MAL in the TLR signaling pathway (Nature, 2001) GDF 15, immunometabolism and anti-inflammatories (An Rev Pharmacol Tox, 2026) Itaconate and regulation of inflammation (Nat Metab, 2024) Time stamps by Jolene Ramsey . Thanks! Music by Tatami . Logo image by Blausen Medical Send your immunology questions and comments to [email protected] Information on this podcast should not be construed as medical advice.